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Abstract: The non-enzymatic addition of glucose (glycation) to circulatory and tissue proteins is a 
ubiquitous pathophysiological consequence of hyperglycemia in diabetes. Given the high incidence 
of periodontitis and diabetes and the emerging link between these conditions, it is of crucial im-
portance to define the basic virulence mechanisms employed by periodontopathogens such as Por-
phyromonas gingivalis in mediating the disease process. The aim of this study was to determine 
whether glycated proteins are more easily utilized by P. gingivalis to stimulate growth and promote 
the pathogenic potential of this bacterium. We analyzed the properties of three commonly encoun-
tered proteins in the periodontal environment that are known to become glycated and that may 
serve as either protein substrates or easily accessible heme sources. In vitro glycated proteins were 
characterized using colorimetric assays, mass spectrometry, far- and near-UV circular dichroism 
and UV–visible spectroscopic analyses and SDS-PAGE. The interaction of glycated hemoglobin, se-
rum albumin and type one collagen with P. gingivalis cells or HmuY protein was examined using 
spectroscopic methods, SDS-PAGE and co-culturing P. gingivalis with human keratinocytes. We 
found that glycation increases the ability of P. gingivalis to acquire heme from hemoglobin, mostly 
due to heme sequestration by the HmuY hemophore-like protein. We also found an increase in 
biofilm formation on glycated collagen-coated abiotic surfaces. We conclude that glycation might 
promote the virulence of P. gingivalis by making heme more available from hemoglobin and facili-
tating bacterial biofilm formation, thus increasing P. gingivalis pathogenic potential in vivo. 
Keywords: periodontitis; diabetes; glycation; Porphyromonas gingivalis; heme; HmuY; hemoglobin; 
albumin; collagen; pathogenesis 
 
1. Introduction 
Periodontitis belongs to a group of multifactorial, non-communicable infectious dis-
eases characterized by inflammation and the destruction of tooth-supporting tissues. An 
altered or disturbed mutualism between oral microbiome members results in dysbiosis 
with local injury and subsequently, in systemic diseases [1–7]. There is growing evidence 
that a two-way relationship exists between periodontitis and diabetes: diabetes increases 
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the risk of periodontitis and periodontitis is associated with compromised glycemic con-
trol [8–12]. Diabetic patients, mostly those displaying poor glycemic control, experience 
severe forms of gingivitis and are at a high risk of periodontitis onset and progression [13–
15]. The pathogenic process that links these two diseases results from upregulated inflam-
mation arising from each condition exerting mutually adverse effects [16]. Diabetes in-
creases the risk of periodontitis by contributing to increased inflammation in the perio-
dontal tissues, leading to the activation of local immune and pro-inflammatory responses, 
local tissue damage, increased breakdown of the periodontal connective tissues and re-
sorption of alveolar bone and the exacerbation of periodontitis. Periodontopathogens and 
their products, together with inflammatory cytokines and other locally produced media-
tors in the inflamed periodontal tissues, enter circulation and contribute to up-regulated 
systemic inflammation. This leads to impaired insulin signaling, insulin resistance and the 
exacerbation of diabetes [17,18]. 
Diabetic patients suffer from a variety of systemic health problems, resulting primar-
ily from glycated circulatory and tissue proteins. These arise from the non-enzymatic re-
action between amino groups and reducing sugars, resulting mainly in the addition of 
glucose moieties to the proteins. This chemical modification involves the Maillard reac-
tion, forming first the Schiff base, which undergoes rearrangement to an N-linked (glyco-
sylamine) product. Further reactions follow, via Amadori rearrangement, to ketosamines 
and resulting finally in increased levels of Advanced Glycation End (AGE) products 
[19,20]. The main target of these glycation reactions is the amino group of lysine residues, 
which reduces the availability of these side chains in proteins [21]. It has been demon-
strated that glycation may change both structure and function, with profound effects on 
both the biochemical and physiological properties of such proteins. For instance, the gly-
cation of albumin decreases its ability to bind and carry ligands [22–24]. In experimental 
animals, the half-life of circulating glycated albumin is decreased and glycated albumin is 
degraded about 33% faster than the un-glycated protein [22]. Glycated hemoglobin shows 
increased oxygen binding and decreased oxygen unloading [25], a factor that may con-
tribute to the anaerobic nature of the periodontal tissues and periodontal pocket. Other 
serious effects of hemoglobin glycation involve the promotion of thermal instability, oxi-
dation to the methemoglobin form and, importantly, the induction of a loss of iron and 
heme transfer from glycated hemoglobin subunits to serum albumin [26,27]. 
Clinical studies have demonstrated that there is increased colonization by “red com-
plex” microorganisms (Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola) 
in the subgingival plaque of individuals with type 2 diabetes [14]. Moreover, the increased 
numbers of black pigmented anaerobes at such sub-gingival sites also correlates with dis-
ease severity and the raised levels of glycated proteins not only in serum, but also in gin-
gival crevicular fluid [14,15,28–30]. It has been reported that the gingival crevicular fluid 
from the periodontal lesions of diabetic patients contains both glycated albumin and gly-
cated hemoglobin [31], and that elevated levels of glycated hemoglobin are associated 
with an increased inflammatory status and correlates with the severity of periodontitis in 
diabetic patients [28]. One may speculate that the elevation of these glycated hemopro-
teins may represent a more efficient nutrient supply for periodontopathogens, which 
could result in the stimulation of the growth and/or pathogenic potential of subgingival 
microorganisms. One other protein, which is also glycated in vivo, is collagen, the most 
abundant, long-life structural protein in the human body [29,32,33]. This protein has a 
hierarchical arrangement originating from the polymerization of collagen molecules into 
fibrils and, owing to its abundant lysine residues, is also subjected to intermolecular cross-
linking from glycation [29,32–36]. 
It is also noteworthy that P. gingivalis, a keystone etiologic agent of chronic periodon-
titis, is more frequently detected in periodontal pockets of diabetic patients with raised 
glycated hemoglobin (HbA1c) levels [30], and that increased gingival tissue bleeding is 
seen in diabetic individuals [37,38]. This raises the question as to whether heme and iron 
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availability shape the microbiological profile in the plaque of diabetic patients. In this con-
text, it is important to note that in order to survive in the host environment, and initiate 
and progress periodontitis, black-pigmented anaerobes, such as P. gingivalis, must acquire 
heme as a sole source of iron and protoporphyrin IX [39]. Moreover, heme is an important 
key virulence factor for P. gingivalis. 
Our previous work has resulted in an extensive biochemical and functional charac-
terization of one of the major P. gingivalis heme uptake systems (Hmu), has progressed 
our understanding of the mechanisms of heme acquisition and revealed the leading role 
played by the TonB-dependent outer membrane receptor HmuR and hemophore-like 
HmuY proteins [40–48]. Specifically, we demonstrated that HmuR is involved in heme 
transport through the P. gingivalis outer membrane, whereas HmuY is a unique heme-
binding protein, transferring heme to the HmuR. These proteins serve as the first docu-
mented example of a novel, two-component system, comprising an outer-membrane 
transporter and a heme-binding hemophore-like protein. We have also shown that P. gin-
givalis displays a novel heme acquisition paradigm from hemoglobin, whereby oxyhemo-
globin must be first oxidized to methemoglobin, which facilitates heme release. In the case 
of P. gingivalis, this process involves the arginine-specific gingipain protease A (HRgpA) 
[48]. The bacterium is then able to fully proteolyze the more susceptible methemoglobin 
to release free heme, mostly through the proteolytic activity of P. gingivalis lysine-specific 
gingipain K (Kgp) and via heme sequestration by HmuY. P. gingivalis HmuY can capture 
heme directly from methemoglobin [48] and thus functions similarly to classical, bacterial 
hemophores, which are secreted proteins engaged in heme transfer from the host hemo-
proteins to the outer-membrane receptors [49]. HmuY is also able to compete with albu-
min, which is the normal front-line circulatory heme scavenger in vivo [48], as well as 
acquiring heme from serum hemopexin [47]. 
The HmuY protein is associated with the outer membrane of the bacterial cell and 
outer-membrane vesicles (OMVs) through the lipid anchor [50–52], and can be shed in an 
intact, soluble form through the limited proteolytic activity of P. gingivalis Kgp [45,50]. 
This is especially important since not only whole P. gingivalis cells but also OMVs can be 
internalized into endothelial and epithelial cells via an actin- and lipid raft-mediated en-
docythic pathway and, therefore, have been shown to play a role in establishing coloniza-
tion, carrying and transmitting virulence factors and modulating the host response [53–
55]. From this perspective, their cargo components, such as the well documented gingi-
pain proteases and HmuY [50–52,56–58], appear to be important both for P. gingivalis col-
onization and virulence. Moreover, it has been demonstrated that P. gingivalis residing in 
the oral cavity can translocate to liver cells, causing decreased insulin sensitivity [59]. Im-
portantly, mouse model experiments have revealed that hepatic cells did not harbor P. 
gingivalis cells, but the contents of OMVs led to the attenuation of insulin sensitivity and 
the inhibition of hepatic glycogen synthesis [18]. 
Given the high incidence of periodontitis and diabetes and the emerging link be-
tween these conditions, defining the basic virulence mechanisms employed by P. gingi-
valis is of crucial importance in understanding these microbially mediated disease pro-
cesses. P. gingivalis, selectively enriched by growth in gingival crevicular fluid, is able to 
efficiently degrade the serum iron- and heme-scavenging proteins, which otherwise de-
fend the gingival crevice against microbes by sequestering any free iron and heme [60,61]. 
However, little is known regarding the influence that glycated host proteins within the 
gingival crevice, periodontal pocket and the tissues of the periodontium have upon the 
growth and pathogenic potential of P. gingivalis. Therefore, the general purpose of this 
study was to determine whether glycated proteins are more easily utilized by P. gingivalis, 
whether they have a growth stimulatory effect, and whether they could promote the path-
ogenic potential of this bacterium. 
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2. Results and Discussion 
2.1. Characterization of Glycated Proteins 
Due to the difficulties obtaining sufficient standardized glycated hemoglobin from 
diabetic patients, we employed horse hemoglobin, which was glycated in vitro by incu-
bation with glucose, using a modified protocol previously described by Ch’ng and Mari-
nah [62]. The glycated moieties were further purified from the non-modified proteins us-
ing affinity chromatography, and the samples were analyzed using colorimetric analysis, 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and liquid chro-
matography/mass spectrometry (LC/MS). 
The efficiency of glycation was confirmed using an assay for the presence of 5-hy-
droxymethylfurfural (5-HMF) using the thiobarbituric acid method [63]. From three sep-
arate determinations, we found that the average molar ratio of 5-HMF to hemoglobin sub-
unit was 1.2:1, indicating that each protein subunit was minimally modified by one hexose 
unit (Table S1). It is noteworthy that 5-HMF was also detected in the un-glycated hemo-
globin samples, likely arising from the natural in vivo glycation of hemoglobin in normal 
individuals [64]. The level of glycation in the un-glycated hemoglobin preparations was 
relatively low, with the average molar ratio of 5-HMF to hemoglobin being 0.2, indicating 
one modification per five hemoglobin subunits (Table S2). 
SDS-PAGE analysis (Figure 1a) demonstrated the slower migration of the glycated 
compared to un-glycated hemoglobin, confirming the increased molecular weight due to 
the hexose modifications of the protein. Both hemoglobin samples contained almost equal 
amounts of methemoglobin (95% for glycated and 97% for un-glycated samples); the re-
maining component in both preparations being hemichrome. 
 
Figure 1. Analysis of glycation efficiency. Glycation of (a) hemoglobin, (b) albumin and (c) collagen was examined using 
SDS-PAGE and CBB G-250 staining. Verification of collagen glycation was carried out using samples containing 125 or 25 
µg protein. Hb, hemoglobin; HSA, human serum albumin. 
LC/MS analysis of the glycated hemoglobin used in our study showed a very similar 
pattern of glycation to human hemoglobin both in vivo and in vitro, which is in accord-
ance with the published data (Table S2 and Figure S1a) [65–68]. Interestingly, weak signals 
were also observed on non-lysine sites in the  chain (e.g., on serine at positions 3 and 84 
and on threonine at positions 39 and 137). A study of the reaction of formaldehyde [69] 
found evidence for a reaction with serine and threonine, and the finding here of modifi-
cations on both amino acids is consistent with these residues having reacted similarly with 
the reducing end (an aldehyde group) of the sugar. Importantly, glycated residues 
Lys61(), Lys90(), Lys66() and Lys95() were positioned in the heme pocket, with 
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Lys61() and Lys66() located on the E helix of the - and - chains, which contain the 
histidine residues (His58 and His63, respectively) involved in oxygen binding to the heme 
iron, whilst Lys90() and Lys95() are positioned on the same F8 helix-loop as the proxi-
mal histidines (His87() and His92(), respectively), which are essential in coordinating 
the heme iron to the hemoglobin peptide chains. 
Circular dichroism (CD) spectra demonstrated subtle changes in the secondary struc-
ture of hemoglobin after glycation as compared to the un-glycated protein (Figure 2a; 
shown by arrows). The UV–visible spectra did not reveal significant changes between un-
glycated and glycated hemoglobin (Figure 2b,c). However, the glycated hemoglobin frac-
tion exhibited a greater tendency to release iron compared to the un-glycated protein, as 
determined using the ferrozine assay method (Figure S2), which is in accordance with 
published data demonstrating results from both in vivo and in vitro glycation [26,70]. 
 
Figure 2. Characterization of glycated hemoglobin. (a) (Left) Far- and (right) near-UV CD analysis (averages of 25 repeat 
scans) of glycated and un-glycated hemoglobin. Both spectra were background-corrected by the subtraction of the buffer 
spectrum. Arrows in the near-UV region (260–280 nm) denote the wavelengths at which subtle changes were observed in 
the spectra of the glycated hemoglobin preparations. (b) The UV–visible spectra of the glycated (left panel) and un-gly-
cated hemoglobin (right panel) after phenylboronic acid-affinity chromatography purification. (c) Comparison of redox 
properties of heme bound to glycated and un-glycated hemoglobin. Hb, hemoglobin; A, absorbance. 
According to the manufacturer’s product specification (A8301, Sigma-Aldrich, St. 
Louis, MO, USA) glycated albumin has between 1 and 5 mol of hexose (determined as 
fructosamine) per mol of protein. 
An assessment of the degree of glycation revealed that the glycated collagen com-
prised 30.23 ± 0.48 (n = 3) nmols of 5-HMF per mg of protein, whilst the non-glycated 
collagen control sample contained 1.45 ± 0.09 (n = 3) nmols of 5-HMF per mg of protein. 
These values are within the ranges of the 5-HMF levels found in the insoluble collagens 
extracted from both human and animal species [71]. Based on this assay, we calculated 
that each type I tropocollagen molecule glycated under the above conditions was modi-
fied (to the nearest whole number) by nine glucose additions. This value is similar to the 
predicted number of lysine residues (13) in type I tropocollagen, which are susceptible to 
glycation [72]. 
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Similar to hemoglobin, both the glycated albumin (Figure 1b) and glycated collagen 
fractions (Figure 1c) migrated slightly slower during SDS-PAGE compared to their un-
glycated counterparts, providing evidence of the addition of glucose to the proteins. 
2.2. Glycated Hemoglobin as a Sole Source of Heme for P. gingivalis 
Despite changes in the structure and properties of glycated proteins, and the fact they 
are ubiquitously formed and present in periodontal vascular and connective tissues, gin-
gival crevicular fluid and periodontal pockets during periods of hyperglycemia, nothing 
is known regarding their influence on the growth and virulence of the sub-gingival peri-
odontopathogens. Therefore, we determined any possible growth-promoting ability of 
glycated hemoglobin, whether it might be degraded more readily by P. gingivalis for the 
purposes of heme release, or if heme might be more easily extracted by the HmuY hemo-
phore-like protein for transfer to HmuR at the bacterial surface. 
Rgp and Kgp gingipains act synergistically to degrade hemoglobin, which results in 
the release of heme for cellular uptake and the production of pigment through its cell-
surface deposition in the form of a -oxo heme dimer [73,74]. Although Rgp gingipains 
have lower proteolytic activity toward hemoglobin compared to Kgp, HRgpA is efficient 
in converting oxyhemoglobin into methemoglobin, the latter being more easily attacked 
by Kgp [75] and from which heme can be sequestered by HmuY [48]. Therefore, we first 
examined whether glycated hemoglobin, compared to the un-glycated protein, was a 
more susceptible substrate for gingipains. However, as shown in Figure 3, although no 
significant differences were observed in protease susceptibility in P. gingivalis cultures be-
tween the two hemoglobin preparations, it seems that un-glycated hemoglobin is a 
slightly better substrate for P. gingivalis proteases. To explore this further, we employed 
gingipain mutant strains. Our results showed a similar trend as compared with the wild-
type strain, apart from lower proteolytic activity resulting from the lack of genes encoding 
respective gingipains (Figure 3). These results also confirmed that among all the proteases 
produced by P. gingivalis, the gingipain fraction was mainly responsible for hemoglobin 
degradation. 
 
Figure 3. Susceptibility of hemoglobin to proteolytic activity of P. gingivalis. W83, wild-type P. gingivalis strain; kgp, 
rgpArgpB, kgprgpArgpB, gingipain mutant strains lacking functional genes encoding lysine-specific Kgp and/or ar-
ginine-specific RgpA and RgpB, constructed in W83 strain. 
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The three-dimensional rendering of the horse methemoglobin molecule (PDB ID: 
2MHB) [76] (Figure S1) revealed that the glycated lysine residues were mainly surface 
located (Lys16(), Lys8(), Lys82() and Lys144()), and it is likely that this would slightly 
reduce the efficiency of the gingipain degradation of the glycated protein by blocking the 
Kgp target residues. Additionally, when we incubated hemoglobin samples with P. gingi-
valis cells, it was revealed that heme was released from the un-glycated hemoglobin more 
easily compared to the glycated protein (Figure 4). Nevertheless, we found that the addi-
tion of glycated hemoglobin to basal medium (BM) as a sole source of heme resulted in a 
slightly, but not statistically significant increased growth of P. gingivalis compared to that 
in the presence of the un-glycated protein (Figure 5). This shows that despite the fact that 
glycated hemoglobin is degraded slightly less efficiently by P. gingivalis proteases, it could 
be used as a heme source as efficiently as un-glycated hemoglobin. 
 
Figure 4. Heme release from hemoglobin after incubation with P. gingivalis. Absorbance of the sam-
ples was measured at 406 nm (A406nm), and the heme release is shown as the decrease in A406nm with 
time. Control samples did not include P. gingivalis. The data are expressed as mean ± SD from three 
replicates. 
 
Figure 5. Analysis of P. gingivalis growth ability in liquid culture media. BM, basal medium; BM + 
Hm; BM supplemented with 7.7 M hemin; BM + Hb, BM supplemented with 2 M un-glycated or 
glycated hemoglobin; OD600, optical density of the culture measured at 600 nm. The data are ex-
pressed as mean ± SD values from two independent experiments, each performed in two replicates. 
One notable observation was the difference in the ability of the HmuY to sequester 
heme from the glycated and un-glycated hemoglobin (Figure 6). Specifically, the HmuY-
Fe(III)-heme complex formed more rapidly from the glycated than from un-glycated he-
moglobin (relative heme binding constant for HmuY of 16.6 ± 1.0 × 10−3 s−1 from a glycated 
sample compared to 11.3 ± 0.7 × 10−3 s−1 for the un-glycated sample). Thus, although both 
hemoglobin preparations contained almost equal concentrations of methemoglobin, there 
was an approximately 1.5-fold increase in the rate of heme acquisition. These data suggest 
that glycated hemoglobin is a more ready substrate as a source of heme than un-modified 
hemoglobin. The far-UV CD analysis showed that both glycated and un-glycated hemo-
globin shared a high similarity in secondary structure, indicating that the α-helix strands 
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(180–200 nm peak) and -sheets (200–240 nm trough) were largely unaffected by the gly-
cation process (Figure 2b,c). We can conclude that the in vitro glycation process did not 
result in the unfolding of the protein, a finding contrary to the work of Sen et al. [26], but 
this may be explained by the fact that structural changes can occur during longer periods 
of glycation. In the near-UV region, however, there were subtle differences between the 
two spectra: the peak intensity between 260 and 280 nm was increased for the glycated 
hemoglobin (Figure 2a). In addition, a small change was seen in the shoulder at 270 nm in 
the un-glycated hemoglobin sample, which was less prominent than in the glycated he-
moglobin. Taken together, these spectra indicated that whilst the secondary structure was 
unaffected, in vitro glycation appeared to alter the spatial disposition of the aromatic 
amino acids, e.g., the orientation of the phenylalanine (260–270 nm) and/or tryptophan 
(275–285 nm region) residues. Moreover, the glycation of lysine residues located in the 
hemoglobin heme-binding pocket may result in structural changes in this region, result-
ing in an increased accessibility of heme for HmuY. Indeed, it is known that the heme-
globin linkage is weakened in both glycated hemoglobin and myoglobin, which increases 
the rate of heme transfer to serum albumin [26,77]. Whilst as yet we cannot provide an 
exact mechanism for the increase in heme extraction from glycated hemoglobin by HmuY, 
it is notable that Lys61() and Lys66() were found to be glycated, which is in keeping 
with other work [78,79]. These residues lie within the heme pocket on the E helix of the - 
and -chains, carrying the residues His58 and His63, which control oxygen binding to the 
heme iron. As these lysine residues cooperate with the histidine in oxygen binding, it is 
likely that glycation at these sites may not only reduce oxygen affinity [80,81], but desta-
bilize the heme to protein interactions. In addition, it is known that glycated oxyhemoglo-
bin and oxymyoglobin both have an increased propensity to auto-oxidize to their met-
forms [26,77]. This may influence heme extraction by HmuY, since methemoglobin is its 
preferred substrate [39], although it should be noted that both glycated and un-glycated 
hemoglobin had similar levels of methemoglobin (95 and 97%, respectively). 
 
Figure 6. Comparison of HmuY-Fe(III)heme complex formation from hemoglobin. Glycated (close 
circles) and un-glycated (open circles) hemoglobin (64 μM with respect to monomer) samples were 
incubated with an equimolar concentration of HmuY. The combined integrated areas of 525 and 560 
nm Q bands (from difference spectra) were used as a measure of HmuY-Fe(III)heme complex for-
mation. The data points are an average from three separate experiments (mean ± SD). 
Based on our results, we assumed that although there were differences in hemoglo-
bin degradation and heme release and/or heme extraction between glycated and un-gly-
cated hemoglobin, these might not be sufficient to impart a major advantage for P. gingi-
valis growth in liquid culture media under laboratory conditions. Important features of P. 
gingivalis-mediated diseases include the ability of the bacterium to infect and disseminate 
through host cells and tissues and subvert host immunological surveillance and defense 
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mechanisms [1,53,82]. Therefore, we examined how P. gingivalis infected host cells cul-
tured in the presence of hemoglobin as a main sole source of heme. We found that the 
glycation of hemoglobin slightly increased the general infection ability towards cultured 
keratinocytes (Figure 7). This effect was mainly caused by the slightly higher tendency of 
bacteria to attach to, rather than to invade, the keratinocytes. Based on these results, one 
may assume that glycation might improve the ability of P. gingivalis to survive and sub-
sequently migrate into deeper layers of the epithelium using the intercellular pathway 
rather than the intracellular one. It is worth mentioning, however, that differences be-
tween cultures carried out in the presence of un-glycated and glycated hemoglobin were 
not statistically significant. One of the explanations of this effect could be the employment 
in our experiments of a simple model composed of keratinocytes cultures, which did not 
allow us to observe the invasion process performed under in vivo conditions. A recent 
study, based on the vascularized three-dimensional gingival model with an epithelial bar-
rier expressing cell–cell junctions using collagen microfibers, demonstrated such a possi-
bility [83]. 
 
Figure 7. Infection assay. Immortalized human gingival keratinocytes were incubated with P. 
ginvivalis cells in the presence of glycated or un-glycated hemoglobin (Hb). The number of viable 
bacteria was determined as colony forming units (CFU) per mL. Adhesion, the number of live bac-
teria attached to the surface of keratinocytes; invasion, the number of live bacteria that invaded 
keratinocytes; infection, the total number of live bacteria in co-cultures of P. gingivalis-keratinocytes. 
The data are expressed as mean ± SD from one representative experiment showing a similar trend 
in three independent experiments. 
2.3. Glycated Albumin as a Sole Source of Heme for P. gingivalis 
It has been demonstrated that the environment of sub-gingival dental plaque, which 
is enriched in serum albumin as a result of inflammatory processes, selects for the pres-
ence and encourages the growth of black-pigmented anaerobes, including P. gingivalis 
[60]. This may have the effect of increasing periodontal tissue destruction at such sites, 
since this is accompanied by increased collective proteolytic activity of the organisms pre-
sent. In view of this, we examined whether glycated albumin, compared to the un-gly-
cated protein, might serve as a more susceptible substrate for gingipain activity. However, 
similar to hemoglobin, as shown in Figure 8, no significant differences were observed in 
the susceptibility of the two albumin species to proteolysis in P. gingivalis cultures. 
Unlike hemoglobin, we found only a slight increase in heme sequestration by HmuY 
from glycated versus un-glycated albumin (Figure S4). Shaklai et al. [22] showed that the 
glycation of human serum albumin does not alter heme binding. We also showed that 
both the un-glycated and glycated albumin exhibited similar UV–visible spectra, demon-
strating a similar heme-binding efficiency (Figure S3). This can be explained by the fact 
that the main glycation site (Lys525) [84] and the heme binding site (His146 and Tyr161) 
are not in close proximity within the albumin molecule (Figure S1b). This is in contrast to 
glycated hemoglobin, where a relaxation of heme binding occurs [26]. 




Figure 8. Susceptibility of albumin to proteolytic activity of P. gingivalis. W83, wild-type P. gingivalis 
strain; kgp, rgpArgpB, kgprgpArgpB, gingipain mutant strains lacking functional genes en-
coding lysine-specific Kgp and/or arginine-specific RgpA and RgpB, constructed in W83 strain. 
2.4. Glycated Collagen as a Substratum for P. gingivalis 
Collagen is the most abundant, long-lived structural protein and the main compo-
nent of the basal structures of connective tissues [85]. In the oral cavity, type I collagen is 
an important matrix constituent of the hard and soft tissues, including dental pulp, den-
tine, periodontal ligament and alveolar bone. Type I collagen comprises 70% of the total 
collagen in periodontal ligament, where it forms a highly cross-linked matrix. To partially 
mimic this substrate, we used type I collagen derived from a bovine Achilles tendon, 
which was glycated by incubation with glucose. 
It has been suggested that the glycation of collagen may promote bacterial adhesion, 
and even penetration into the collagen gel subsurface, resulting in subsequent biofilm for-
mation. A recent report showed that glucose-induced crosslinking of collagen increased 
biofilm formation by Streptococcous mutans, but not by Streptococcus sanguinis [59]. Mem-
bers of the oral microbiome can also utilize type I collagen as a substratum for both at-
tachment and biofilm formation [86]. For this purpose, P. gingivalis uses several proteins, 
including RgpA and adhesins [87–89]. As shown in Figure 9, the glycation of collagen 
increased the tendency for biofilm formation by P. gingivalis on surfaces coated with the 
modified protein compared to those coated with un-glycated collagen, as well as to sur-
faces coated with bovine serum albumin, and un-coated abiotic surfaces. 




Figure 9. Biofilm formation. Ability of biofilm formation of P. gingivalis on glycated and un-glycated 
collagen-coated plates. Bovine serum albumin (BSA)-coated and un-coated (abiotic) plates were 
used as controls. *** p < 0.01; **** p < 0.001; ns, not significant; A, absorbance. 
We did not find any differences between un-glycated and glycated collagens in terms 
of protein degradation by P. gingivalis proteases (data not shown). Due to the large num-
ber of lysine residues potentially available for glycation in collagen, one could predict it 
to be a less amenable source of amino acids for P. gingivalis due to blocking the access of 
Kgp to cleavage sites even when the native triple helix is unwound. However, although 
we did not find a difference in digestion between glycated and un-glycated collagen in 
our in vitro assay, one may not rule out the possibility that glycated collagen, compared 
to its un-glycated counterpart, could be subjected to more efficient destruction in situ 
within the periodontal tissue matrix. One of the possible explanations is the more complex 
structure of gingival tissue composed of an epithelial cell layer and a dense fibrillar con-
nective tissue, the latter comprising mostly type I collagen. 
3. Materials and Methods 
3.1. Bacterial Stains and Growth Conditions 
P. gingivalis W83 wild-type and kgp, rgpArgpB, kgprgpArgpB gingipain mu-
tant strains, lacking respective functional genes, constructed in the W83 genetic back-
ground [90–92], were grown anaerobically (Whitley A35 anaerobic workstation; Bingley, 
UK) at 37 °C for 5 days on blood agar plates composed of Schaedler broth (containing 
hemin and L-cysteine), and supplemented with 5% sheep blood and menadione (Bimax-
ima, Lublin, Poland). Mutant cells were grown with an addition of appropriate antibiotics. 
These cultures were inoculated into liquid basal medium (BM) comprising 3% trypticase 
soy broth (Becton Dickinson, Sparks, MD, USA), 0.5% yeast extract (Biomaxima), 0.5 mg/l 
menadione (Fluka, Munich, Germany) and 0.05% L-cysteine (Sigma-Aldrich, St. Louis, 
MO, USA). To grow bacteria under high iron/heme conditions (BM + Hm), BM was sup-
plemented with 7.7 M hemin (Fluka). To grow bacteria under low iron/heme conditions 
(BM + DIP), hemin was not added to BM and iron was chelated by an addition of 160 M 
2,2-dipyridyl (DIP; Sigma-Aldrich). To assess the ability of P. gingivalis to grow in BM, 
where the source of heme was 2 M glycated or un-glycated hemoglobin, bacteria were 
grown in BM + Hm for 24 h, followed by 2 passages in BM + DIP, starting at optical density 
at 600 nm (OD600) of at least 0.25. Then, bacteria were centrifuged (4000× g, 20 min, 4 °C), 
washed once with 20 mM sodium phosphate buffer, pH 7.4, supplemented with 140 mM 
NaCl (PBS), and again centrifuged. These samples were used to inoculate fresh BM + Hb 
culture media at an initial OD600 of 0.2. The growth was determined by measuring the 
OD600 over time. 
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Escherichia coli Rosetta (DE3)RIL strain (Agilent Technologies, Santa Clara, CA, USA) 
was cultured under standard aerobic conditions. 
3.2. Preparation and Characterization of Glycated Proteins 
Hemoglobin prepared from fresh horse erythrocytes (TCS Biologicals, Wirral, Chesh-
ire, UK) [93] was glycated in vitro by incubation with glucose using a slight modification 
of the methods previously reported [20,21]. Briefly, oxyhemoglobin (0.5 mM) containing 
250 mM glucose plus 100 U/mL penicillin and 100 μg/mL streptomycin in Tris-HCl buffer, 
pH 7.5, containing 150 NaCl (TBS) was applied to Whatman grade 1 filter papers and 
incubated sterilely for 7 days at 37 °C. Un-glycated control hemoglobin was produced 
under the same conditions but without a glucose addition. Following incubation, the he-
moglobin was desorbed from the filter paper in the above buffer and residual glucose and 
buffer constituents were removed by dialysis at 5 °C, firstly against deionized water, then 
against a 0.25 M ammonium acetate buffer, pH 8.5, and finally against the above buffer 
containing 20 mM magnesium chloride. The glycated fraction was enriched using phenyl-
boronic acid (PBA) resin (Sigma-Aldrich) affinity chromatography according to Middle et 
al. [94]. PBA-bound glycated hemoglobin was desorbed from the resin by the addition of 
1 mL of 0.25 M ammonium acetate, pH 8.5, containing 0.2 M sorbitol, and then dialyzed 
against deionized water at 5 °C to remove residual sorbitol. 
The concentration of oxyhemoglobin, methemoglobin and hemichrome species in 
these preparations was calculated as described previously [74]. The degree of glycation of 
hemoglobin was determined using a thiobarbituric acid assay [63] and chemical modifi-
cation was verified using LC/MS. For this purpose, 16 µM (with respect to tetramer) of the 
glycated and un-glycated hemoglobin samples, as prepared above, were dialyzed for 2 h 
at 5 °C against 0.1 M sodium phosphate buffer, pH 7.4. The hemoglobin samples were 
diluted 1:10 in the above buffer and incubated overnight at 37 °C with 0.5 µg of trypsin 
(Sigma-Aldrich). Samples were desalted by reversed-phase chromatography using 
ZipTips (Thermo Scientific, Whaltam, MA, USA). Aliquots of 0.2 µg were delivered into 
a Triple TOF 5600 mass spectrometer (Sciex, Framingham, MA, USA) by automated in-
line reversed phase liquid chromatography (LC), using an Eksigent NanoUltra cHiPLC 
System (Sciex) mounted with microfluidic trap and analytical column (15 cm × 75 μm) 
packed with ChromXP C18-CL 3 μm (Sciex). Spectra were acquired automatically in posi-
tive ion mode using information-dependent acquisition powered by Analyst TF 1.5.1. soft-
ware (Sciex). Protein sequence coverage was determined using ProteinPilot software v4.0 
(Sciex). Glycated peptides identified by ProteinPilot were confirmed using PeakView soft-
ware (Sciex) to extract parent ions of the appropriate m/z for peptide plus hexose (ex-
tracted ion count, XIC), and the area under the curve of each XIC peak was used to assess 
the presence or absence of the modified peptide in treated and untreated samples. 
We chose type I collagen from bovine Achilles tendon as a representative substrate 
for glycation since type I collagen makes up approximately 70% of the total collagen in 
the dense connective tissue of the periodontal ligament. In vitro glycation of type I insol-
uble collagen with glucose was carried out as follows. In order to provide access of glucose 
to the otherwise insoluble tissue, we took advantage of the observation of Glimcher et al. 
[95] that insoluble collagen fibers can become hydrated by exposure to dilute organic acids 
such as acetic acid. To achieve this step, powdered bovine Achilles tendon (Sigma-Al-
drich) was firstly suspended at a concentration of 1% (w/v) in 0.05 M acetic acid and al-
lowed to swell at 4 °C for 48 h, with occasional stirring. Following this, the acetic acid in 
the suspension was neutralized by the addition of 1 tenth volume of 1 M sodium phos-
phate buffer, pH 6.8, and the collagen suspension was homogenized on ice using an Ultra 
Turrax (IKA Labortechnik, Staufen, Germany) tissue homogenizer for 5 min. To achieve 
glycation, we firstly added antimicrobial agents, sodium azide (final concentration 0.065% 
w/v) and penicillin and streptomycin to final concentrations of 100 IU/mL and 1µg/mL, 
respectively, as described above. For glycation, powdered D-glucose was added slowly to 
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give 1.25 M, whilst this was omitted from the control sample. Samples were then incu-
bated at 37 °C for 35 days and then dialyzed against repeated changes of de-ionized water 
at 4 °C to remove buffer salts and glucose; the removal of the latter from the dialysis re-
tentate was verified by assay using the Glucose Oxidase Activity Assay kit (Sigma-Al-
drich). The preparations were stored frozen at −20 °C until required. To determine the 
degree of glycation, known volumes of the liquid samples were dried to constant weight 
at 40 °C, weighed and then assayed for 5-HMF as described above. 
Un-glycated and glycated human serum albumin samples were purchased from 
Sigma-Aldrich (A3782 and A8301, respectively). The albumin-heme complex was pre-
pared by incubating a 100 M stock solution of human albumin in PBS at a 1:1.2 protein 
to heme molar ratio and subsequently passed through 7K MWCO Zeba™ Spin Desalting 
Columns (Thermo Scientific) [47,96] to ensure that no un-complexed heme remained. Al-
bumin in complex with heme was analyzed using UV–visible spectroscopy. 
Determination of secondary structure and heme-binding properties of un-glycated 
and glycated hemoglobin was carried out using near- and far-UV CD and UV–visible 
spectroscopies, respectively. CD analysis of hemoglobin was carried out on a Jasco 1100 
circular dichroism spectrophotometer. Far- and near-UV data analysis was completed for 
the 180–260 nm and 260–320 nm wavelength regions, respectively. Experiments were con-
ducted at 20 °C using hemoglobin concentrations of 0.5 and 5 µM (with respect to te-
tramer), for far- and near-UV analysis, respectively. Samples for analysis were first dia-
lyzed against 0.1 M phosphate buffer, pH 7.4, to remove chloride ions and Tris, which 
otherwise would absorb at 180–200 nm, and were scanned 25 times and corrected against 
a control buffer. To analyze redox properties, 10 mM sodium dithionite (Sigma-Aldrich) 
prepared in PBS was used as the reductant [44,47,96]. 
Analysis of iron release from hemoglobin was carried out using the ferrozine assay 
method as described previously [97–99]. 
The efficiency of glycation of all proteins was also examined using sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Coomassie Brilliant Blue G-
250 (CBB) staining [47,96]. 
3.3. Analysis of Heme Release from Hemoglobin 
To determine the ability of heme release from glycated and un-glycated hemoglobin 
by P. gingivalis, bacteria were grown in BM + Hm for 3 passages. Then, bacteria were cen-
trifuged (4000× g, 20 min, 4 °C), washed once with PBS, and centrifuged. Analysis of heme 
release was carried out in the reaction buffer (50 mM Tris-HCl, pH 7.5, supplemented with 
150 mM NaCl, 5 mM CaCl2 and 0.05% Tween 20) at room temperature, at a final bacterial 
culture OD600 equal to 0.15 and with hemoglobin added at a final concentration of 3 µM. 
Absorbance of the samples was measured at 406 nm (A406nm) and the heme release was 
shown as the decrease in A406nm over time. Control samples omitted P. gingivalis. For each 
sample, a blank sample was prepared containing all components except hemoglobin. 
3.4. Analysis of Proteins Susceptibility to Proteolysis 
Total proteolytic activity of the wild-type P. gingivalis and gingipain mutant cells 
against glycated and un-glycated proteins was examined using SDS-PAGE. Bacteria were 
grown in BM + Hm for 3 passages. Proteins were treated with P. gingivalis cultures at an 
OD600 equal to 0.5. The reaction was carried out at 37 °C in 50 mM Tris-HCl, pH 7.5, sup-
plemented with 150 mM NaCl, 5 mM CaCl2 and 0.05% Tween 20. At given time points, 30 
µL of the samples was taken out and treated with a Protease Inhibitor Cocktail (Bimake, 
Houston, TX, USA), supplemented with 1 mM EDTA (Roth, Frederikssund, Denmark). 
The degradation of the proteins was analyzed by SDS-PAGE and proteins were stained 
with CBB as reported previously [47,96]. 
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3.5. Protein Overexpression and Purification 
HmuY protein was overexpressed in E. coli Rosetta (DE3)RIL cells (Agilent Technol-
ogies, Santa Clara, CA, USA) and purified from a soluble fraction obtained from E. coli cell 
lysate as described previously [47,96]. 
3.6. Heme-Protein Complex Formation and Analysis 
Heme (hemin chloride; Fluka) solutions were prepared as reported previously 
[47,48,96]. Formation of heme-protein complexes was examined in PBS. UV–visible spec-
tra were recorded in the range 250–700 nm with a double beam Jasco V-650 spectropho-
tometer using cuvettes with 10 mm path length. To analyze the redox properties of the 
heme iron, 10 mM sodium dithionite (Sigma-Aldrich) prepared in PBS was used as the 
reductant [44,47,96]. 
3.7. Heme Sequestration Experiments 
Co-incubation of glycated and un-glycated hemoproteins with the purified HmuY 
was carried out in PBS at 37 C and monitored using UV–visible spectroscopy under oxi-
dizing conditions [47,95]. To demonstrate heme sequestration, hemoglobin (64 µM on a 
subunit basis) and albumin-heme complex (5 M) were incubated at 20 C with equimolar 
concentrations of HmuY. The UV–visible spectra were monitored at the indicated time 
points. The measurements were started immediately after mixing the HmuY protein with 
hemoglobin or albumin (time 0). The HmuY ability of heme sequestration from glycated 
and un-glycated hemoglobin was determined as previously described [98] by measuring 
the progressive increase in the area of the 525 and 560 nm Q bands of the HmuY-
Fe(III)heme complex. The rate constant of HmuY-Fe(III)-heme association was calculated 
using a one-phase exponential association curve as previously described [98,100]. The 
HmuY ability of heme sequestration from glycated and un-glycated albumin was deter-
mined using difference absorbance spectra at 414 nm. 
3.8. Biofilm Formation 
The ability of P. gingivalis to form biofilms on the abiotic surfaces coated with bovine 
serum albumin (BSA; Sigma-Aldrich) or glycated and un-glycated collagen was examined 
as described previously with minor modifications [50]. Briefly, a 96-well plate was coated 
with collagen (200 µg/well) overnight at 4 °C. Then, wells were washed three times with 
PBS and unbound sites blocked with 1% BSA for 1 h at 37 °C, followed by washing three 
times with PBS. Wells coated with 200 µL of 1% BSA or un-coated wells were used as 
controls. Overnight cultures of P. gingivalis were centrifuged (4000× g, 20 min, 4 °C), 
washed once with PBS, and centrifuged. Bacteria were suspended in PBS to OD600 equal 
to 1.0 and 200 µL of bacterial suspension in PBS was added to the wells and incubated for 
1 h at 37 °C. Then, wells were washed three times with PBS, cells stained with crystal 
violet solution (Roth) for 15 min, washed five times with PBS, and cell-bound crystal violet 
was solubilized by addition of 100 µL ethanol. Absorbance of all samples was measured 
at 570 nm. 
3.9. Infection Assay 
Immortalized human gingival keratinocytes (Gie-No3B11; ABM, Richmond, British 
Columbia, CA, USA) were grown in TM-040 medium (ABM), supplemented with 2% 
heat-inactivated fetal bovine serum (FBS; Cytogen, Zgierz, Poland), 2 mM L-glutamine 
(Cytogen), 100 U/mL penicillin and 100 μg/mL streptomycin (Cytogen) in a humidified 
atmosphere of 95% air and 5% CO2 at 37  °C in a CO2 incubator (Panasonic Healthcare Co. 
Ltd., Sakata, Oizumi-Machi, Ora-Gun Gunma, Japan). Gie-No3B11 cells were seeded at 
1.0 × 104/mL in 24-well plates for 24 h. Live P. gingivalis W83 cells were grown to the early 
stationary phase in BM + Hm, pelleted by centrifugation (4000× g, 20 min, 4 °C), and 
washed twice with PBS. Bacteria were added to keratinocytes cultured in DMEM medium 
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(Sigma-Aldrich) supplemented with 2 µM glycated or 2 µM un-glycated hemoglobin 
without antibiotics in 24-well plates at a multiplicity of infection (MOI) of 100 and incu-
bated for 4 h at 37 °C. Then, the medium was collected and spread on ABA plates in an 
appropriate dilution. To the remaining samples, fresh DMEM medium or medium sup-
plemented with 300 μg/mL gentamicin and 200 μg/mL metronidazole was added. After 1 
h, the cells were washed 3 times with PBS and lyzed to determine the number of live cells 
present inside the host cells. The experiment was carried out three times on two independ-
ent biological samples, each sample examined in three technical replications. 
3.10. Bioinformatic and Statistical Analyses 
A three-dimensional model of hemoglobin was constructed using protein structure 
deposited in RCSB PDB data base (PDB ID: 2MHB) [76] as a template and the Accelrys 
Discovery Studio 2016 Client (BIOVIA; San Diego, CA, USA) visualizer (now available 
as https://discover.3ds.com/discovery-studio-visualizer-download, accessed on 11 Octo-
ber 2021). A three-dimensional model of albumin was constructed using the protein struc-
ture deposited in the RCSB PDB data base (PDB ID: 1N5U) as a template and the Swiss 
PDB Viewer program [101]. 
The statistical analysis was performed using a one-way ANOVA test. In the infection 
assay, the two-way ANOVA test was employed. Data were expressed as mean values ± 
standard deviation (mean ± SD). For statistical analysis, the GraphPad software 
(GraphPad Prism 5.0 Inc., San Diego, CA, USA) was used. 
4. Conclusions 
In this study, we examined the properties of three commonly encountered proteins 
in the periodontal environment that are known to become glycated in vivo and that may 
serve as either protein substrates or easily accessible heme sources. We chose proteins 
differing in degrees of glycation (serum albumin being the faster), rates of protein turno-
ver (collagen being the slower) and hemoglobin being the main heme source for P. gingi-
valis. Our results showed that the non-enzymatic glycation of two abundant proteins 
found in the periodontal environment, hemoglobin and collagen, might contribute to an 
increase in the pathogenic potential of P. gingivalis in vivo. 
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